Warburg Pincus’ integrated global healthcare and consumer group leverages our franchise position in healthcare, our expertise in consumer products and services, and our understanding of the growing convergence between those sectors. With our unparalleled network of industry relationships, global sector expertise and deep local knowledge, we have been a leading private equity firm in the healthcare and consumer industries throughout our history. We remain committed to the approach that has enabled us to discover and nurture high-quality management teams and invest in companies that have compelling value propositions.
We have invested more than $12.5 billion in over 200 healthcare and consumer companies that have a record of fulfilling unmet needs. The portfolio companies currently address:
- demographic and socioeconomic shifts that are driving substantial growth among middle-class consumers in emerging markets across consumer products, services and healthcare;
- continuing opportunities in pharmaceuticals, medical devices and diagnostics to develop innovative products that deliver better medical outcomes while reducing costs; and
- technology-enabled disruptions in the delivery of healthcare, consumer products and consumer services.
We remain committed to the approach that has enabled us to discover and nurture high-quality management teams and invest in companies that have compelling value propositions.